GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Affluent Medical (XPAR:AFME) » Definitions » EV-to-EBITDA

Affluent Medical (XPAR:AFME) EV-to-EBITDA : -5.73 (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Affluent Medical EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Affluent Medical's enterprise value is €75.04 Mil. Affluent Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €-13.09 Mil. Therefore, Affluent Medical's EV-to-EBITDA for today is -5.73.

The historical rank and industry rank for Affluent Medical's EV-to-EBITDA or its related term are showing as below:

XPAR:AFME' s EV-to-EBITDA Range Over the Past 10 Years
Min: -11.79   Med: 0   Max: 0
Current: -5.74

XPAR:AFME's EV-to-EBITDA is ranked worse than
100% of 483 companies
in the Medical Devices & Instruments industry
Industry Median: 16.09 vs XPAR:AFME: -5.74

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), Affluent Medical's stock price is €1.815. Affluent Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.540. Therefore, Affluent Medical's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Affluent Medical EV-to-EBITDA Historical Data

The historical data trend for Affluent Medical's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affluent Medical EV-to-EBITDA Chart

Affluent Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - -11.38 -4.07 -5.49

Affluent Medical Semi-Annual Data
Dec16 Dec17 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -11.38 - -4.07 - -5.49

Competitive Comparison of Affluent Medical's EV-to-EBITDA

For the Medical Devices subindustry, Affluent Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Affluent Medical's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Affluent Medical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Affluent Medical's EV-to-EBITDA falls into.



Affluent Medical EV-to-EBITDA Calculation

Affluent Medical's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=75.035/-13.088
=-5.73

Affluent Medical's current Enterprise Value is €75.04 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Affluent Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €-13.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Affluent Medical  (XPAR:AFME) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Affluent Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.815/-0.540
=At Loss

Affluent Medical's share price for today is €1.815.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Affluent Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.540.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Affluent Medical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Affluent Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Affluent Medical (XPAR:AFME) Business Description

Traded in Other Exchanges
Address
320, Avenue Archimede, Les Pleiades III, Batiment B, Aix-en-Provence, FRA, 13100
Affluent Medical is a medical device company. The company developing innovative, next-generation best-in-class minimally invasive implants to restore key physiological functions in the treatment of heart and vascular diseases.

Affluent Medical (XPAR:AFME) Headlines

No Headlines